Dec 8, 2023 04:07PM
Dec 8, 2023 04:05PM
Nov 14, 2023 04:05PM
Aug 10, 2023 04:05PM
Jun 14, 2023 08:01AM
Jun 14, 2023 08:00AM
May 15, 2023 04:18PM Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
Apr 19, 2023 09:00AM
Apr 19, 2023 09:00AM
Mar 15, 2023 08:00AM
Mar 15, 2023 08:00AM
Mar 7, 2023 08:00AM
Mar 7, 2023 08:00AM
Feb 7, 2023 08:03AM Onconova Therapeutics (ONTX) Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma
Feb 7, 2023 08:00AM
Feb 7, 2023 08:00AM
Dec 19, 2022 04:06PM
Dec 19, 2022 04:05PM
Dec 19, 2022 04:05PM
Nov 14, 2022 04:06PM
Nov 14, 2022 04:05PM Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
Nov 14, 2022 04:05PM
May 26, 2022 05:10PM
May 26, 2022 05:10PM
May 11, 2022 04:05PM
May 11, 2022 04:05PM
Mar 11, 2021 04:05PM
Mar 11, 2021 04:05PM Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
Dec 21, 2020 08:02AM
Dec 21, 2020 08:00AM
Dec 21, 2020 08:00AM
Nov 23, 2020 08:01AM
Nov 23, 2020 08:00AM
Nov 23, 2020 08:00AM
Nov 12, 2020 04:05PM Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 12, 2020 04:05PM
Aug 24, 2020 09:31AM
Aug 24, 2020 07:31AM
Aug 24, 2020 07:30AM
Aug 24, 2020 07:30AM
Aug 12, 2020 04:05PM
Aug 12, 2020 04:05PM Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
Aug 7, 2020 08:00AM
Aug 7, 2020 08:00AM
Aug 4, 2020 08:08AM
Aug 4, 2020 08:00AM
Aug 4, 2020 08:00AM
Jul 29, 2020 01:46PM
Jul 29, 2020 01:30PM Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis
Jul 29, 2020 01:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All